UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Design and experiment of flexible clamping device for pepper plug seedlings

Advances in mechanical engineering, 2022-06, Vol.14 (6)

2022

Volltextzugriff (PDF)

Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management

European journal of cardio-thoracic surgery, 2022-07, Vol.62 (2)

2022

Volltextzugriff (PDF)

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations

Frontiers in oncology, 2021-08, Vol.11, p.681429-681429

2021

Volltextzugriff (PDF)

Pembrolizumab Plus Chemotherapy Versus Chemotherapy Monotherapy as a First-Line Treatment in Elderly Patients (≥75 Years Old) With Non-Small-Cell Lung Cancer

Frontiers in immunology, 2022-02, Vol.13, p.807575-807575

2022

Volltextzugriff (PDF)

Case report: Spontaneous remission in lung carcinoma with a late relapse after adjuvant immunotherapy: Exceptional tumor micro-environment

Frontiers in immunology, 2023-02, Vol.14, p.1106090

2023

Volltextzugriff (PDF)

Design and Experiment of an Integrated Automatic Transplanting Mechanism for Picking and Planting Pepper Hole Tray Seedlings

Agriculture (Basel), 2022-04, Vol.12 (4), p.557

2022

Volltextzugriff (PDF)

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC

Frontiers in oncology, 2021-04, Vol.11, p.671228-671228

2021

Volltextzugriff (PDF)

TP53 Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer

Frontiers in immunology, 2021-09, Vol.12, p.732125-732125

2021

Volltextzugriff (PDF)

The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients

Frontiers in oncology, 2024-06, Vol.14, p.1372532

2024

Volltextzugriff (PDF)

Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation: A Long-Term Survival Analysis

Targeted oncology, 2020-06, Vol.15 (3), p.337-345

2020

Volltextzugriff (PDF)

Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study

Frontiers in oncology, 2021-06, Vol.11, p.691519-691519

2021

Volltextzugriff (PDF)

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients

Frontiers in oncology, 2020-06, Vol.10, p.1049-1049

2020

Volltextzugriff (PDF)

Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells

BMC medical genomics, 2019-03, Vol.12 (Suppl 2), p.38-38, Article 38

2019

Volltextzugriff (PDF)

Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung

Frontiers in oncology, 2021-09, Vol.11, p.714549-714549

2021

Volltextzugriff (PDF)

ctDNA-Profiling-Based UBL Biological Process Mutation Status as a Predictor of Atezolizumab Response Among TP53-Negative NSCLC Patients

Frontiers in genetics, 2021-09, Vol.12, p.723670-723670

2021

Volltextzugriff (PDF)

Design and Experiment of Compound Transplanter for Sweet Potato Seedling Belt

Agriculture (Basel), 2024-10, Vol.14 (10), p.1738

2024

Volltextzugriff (PDF)

Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells

BMC medical genomics, 2022-07, Vol.15 (1), p.1-155, Article 155

2022

Volltextzugriff (PDF)

PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/β-catenin pathway

Cancer cell international, 2021-01, Vol.21 (1), p.18-18, Article 18

2021

Volltextzugriff (PDF)

The clinicopathological and molecular characteristics of resected EGFR‐mutant lung adenocarcinoma

Cancer medicine (Malden, MA), 2022-03, Vol.11 (5), p.1299-1309

2022

Volltextzugriff (PDF)

Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data update

Chinese journal of cancer research, 2022-02, Vol.34 (1), p.28-39

2022

Volltextzugriff (PDF)

Local consolidative therapy for synchronous oligometastatic non‐small cell lung cancer treated with first‐line pembrolizumab: A retrospective observational study

Thoracic cancer, 2022-03, Vol.13 (5), p.732-741

2022

Volltextzugriff (PDF)

Extracellular vesicle long RNA markers of early‐stage lung adenocarcinoma

International journal of cancer, 2023-04, Vol.152 (7), p.1490-1500

2023

Volltextzugriff (PDF)

Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma

Annals of surgical oncology, 2022-09, Vol.29 (9), p.5666-5678

2022

Volltextzugriff (PDF)

Clinical significance of visceral pleural and lymphovascular invasion in surgically resected adenosquamous lung cancer

European journal of cardio-thoracic surgery, 2021-04, Vol.59 (3), p.617-623

2021

Volltextzugriff (PDF)

MEK inhibitor combined with RTK inhibitor (trametinib plus anlotinib) in non-G12C KRAS-mutant non-small cell lung cancer: A new strategy

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8542-8542

2024

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Englisch
(106)
Chinesisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Life Sciences & Biomedicine
(55)
Humans
(21)
Oncology
(17)
Technology
(14)
Physical Sciences
(13)
Lung Cancer
(10)
Chemistry
(9)
Materials Science
(8)
Mutation
(8)
Prognosis
(8)
Animals
(7)
Female
(7)
Materials Science, Multidisciplinary
(7)
Non-Small Cell Lung Cancer
(7)
Patients
(7)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(6)
Gene Expression
(6)
Lung Neoplasms - Genetics
(6)
Lung Neoplasms - Pathology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Frontiers In Oncology
(6)
Wei Sheng Yan Jiu
(6)
Annals Of Oncology
(4)
Plos One
(4)
Annals Of Surgical Oncology
(3)
Frontiers In Immunology
(3)
Agriculture
(2)
Bmc Medical Genomics
(2)
Carbon
(2)
European Journal Of Cardio-Thoracic Surgery
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Design and experiment of flexible clamping device for pepper plug seedlings

Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations

Pembrolizumab Plus Chemotherapy Versus Chemotherapy Monotherapy as a First-Line Treatment in Elderly Patients (≥75 Years Old) With Non-Small-Cell Lung Cancer

Case report: Spontaneous remission in lung carcinoma with a late relapse after adjuvant immunotherapy: Exceptional tumor micro-environment

Design and Experiment of an Integrated Automatic Transplanting Mechanism for Picking and Planting Pepper Hole Tray Seedlings

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC

TP53 Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer

The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients

Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation: A Long-Term Survival Analysis

Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients

Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells

Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung

ctDNA-Profiling-Based UBL Biological Process Mutation Status as a Predictor of Atezolizumab Response Among TP53-Negative NSCLC Patients

Design and Experiment of Compound Transplanter for Sweet Potato Seedling Belt

Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells

PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/β-catenin pathway

The clinicopathological and molecular characteristics of resected EGFR‐mutant lung adenocarcinoma

Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data update

Local consolidative therapy for synchronous oligometastatic non‐small cell lung cancer treated with first‐line pembrolizumab: A retrospective observational study

Extracellular vesicle long RNA markers of early‐stage lung adenocarcinoma

Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma

Clinical significance of visceral pleural and lymphovascular invasion in surgically resected adenosquamous lung cancer

MEK inhibitor combined with RTK inhibitor (trametinib plus anlotinib) in non-G12C KRAS-mutant non-small cell lung cancer: A new strategy

Suchergebnisse filtern